A theme in which fluctuations in the number of patients visiting Japan, particularly Chinese visitors, drive changes in the number of outsourced cell-processing contracts and business performance. This includes both an increase in contracts as inbound demand recovers and the risk of falling short of plans as visitor numbers decline.